Alexandre Theron Shares The Proposals from SFTH on the Implementation of Prophylactic Treatments in Children With Hemophilia
Alexandre Theron, Head of the Pediatric Bone Marrow Transplant and Cell Therapy Unit at CHU Montpellier, shared on LinkedIn:
”We are pleased to announce the publication of the proposals of the SFTH (French Society of Thrombosis and Hemostasis) Paediatricians’ Club on the implementation of prophylactic treatments in children with hemophilia in 2025.
Work carried out with:
Olivia Pineau, Sandrine Meunier, Bayart Sophie, Caroline Oudot and all the members of the club and the support of the SFTH”
Read the full article here.
Article: How to start prophylaxis in untreated children with severe and moderate haemophilia in 2025, opinion of paediatricians from the French Society of Thrombosis and Haemostasis
Authors: Alexandre Theron, Olivia Pineau, Sophie Bayart, Caroline Oudot, Sandrine Meunier
Stay updated on all scientific advances in the field of hemophilia with Hemostasis Today.
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS